Company intelligence / Profile preview

Wallaby Medical

Shanghai, Shanghai, Chinawallabymedical.com ↗

Ownership: Private
Employees: ~700
Development stage: Other

Overview

Wallaby Medical develops and commercializes innovative, clinically validated medical devices for the treatment of neurovascular diseases such as stroke and intracranial aneurysms. Its flagship Avenir® Coil System is FDA-cleared, CE-marked, PMDA-approved, and NMPA-approved. The company has expanded its portfolio through the acquisition of phenox GmbH in 2022, adding flow diverters, stent retrievers with antithrombogenic coatings, aspiration catheters, microcatheters, and more. Products are sold in over 60 countries worldwide[1][2][6].

Therapeutic areas: NeurologyCardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Japan Lifeline Co., Ltd. ("JLL") for distribution in Japan

Beyond the preview

Go deeper on Wallaby Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wallaby Medical.

Explore the full profile